Former oncology biotech agency Leap Therapeutics (LPTX), which earlier this month raised $58.9 million in funding led by Winklevoss Capital to pivot to a digital treasury agency, introduced the acquisition of $50 million of Zcash .
Alongside, the corporate is rebranding as Cypherpunk Applied sciences and can start buying and selling Thursday with new ticker CYPH, learn a Wednesday press launch.
About the one crypto that has risen in worth prior to now weeks, ZEC has greater than doubled because the Leap buys, up one other 12.2% over the previous 24 hours to $523.
LPTX shares rose 369% on Wednesday after information of the worthwhile funding.
Digital asset treasuries pursue a method to lift funds by promoting fairness and debt to build up cryptocurrencies, a playbook pioneered by Michael Saylor’s Technique (MSTR) with bitcoin. They grew to become ubiquitous this yr with dozens of public companies asserting a pivot, however the frenzy has significantly cooled off over the previous months as their share costs tumbled in lots of instances beneath the web asset worth of their digital asset holdings.
“The current weak efficiency of digital asset treasury firms stems from PIPEs dominated by short-term, mercenary capital,” Will McEvoy, chief funding officer of Cypherpunk mentioned in an announcement. “We have taken a special path by constructing a syndicate of value-aligned buyers who consider within the long-term significance of Zcash and privateness for the USA and the world.”
Zcash is designed to supply customers better privateness than mainstream cryptocurrencies like bitcoin . Cypherpunk’s executives considered ZEC as a hedge in opposition to surveillance-driven monetary techniques.
